20% of all entry fees are donated to charity. Click on the logos below to find out more about each one…
Around 60,000 babies in the UK are born too soon every year.
60,000 babies is enough to fill 280 primary schools. This is simply too high.
Babies born early have an increased risk of suffering lifelong health and developmental problems. Premature birth has been linked to disabilities such as cerebral palsy, epilepsy and long term visual and hearing impairments.
Tommy’s believes every baby deserves the best start in life.
They are committed to funding medical research into premature birth and providing comprehensive information to help more mums and dads have a healthy pregnancy and birth. Their specialist Preterm Surveillance Clinic at their St Thomas’ Centre cares for women at risk of premature birth.
They believe that parents need, and deserve, answers when their babies die. Tommy’s exists to answer these questions.
When a baby dies or is born too soon, it leaves their parents with so many questions and emotions.
Sadly, many of these questions will go unanswered as medical science has not yet found out why some babies make it and some do not, why some babies are born early and why some make it to full term.
Tommy’s believes in reducing premature birth; the leading cause of neonatal death in the UK.
Children with Cancer UK is the leading national children’s charity dedicated to the fight against childhood cancer. They fund life-saving research into the causes, prevention and treatment of childhood cancer and work to protect young lives through essential welfare programme.
Scope exists to make this country a place where disabled people have the same opportunities as everyone else. Until then, They’ll be here.
They provide support, information and advice to more than a quarter of a million disabled people and their families every year. They raise awareness of the issues that matter. And with your support, they’ll keep driving change across society until this country is great for everyone.
Prostate Cancer UK has a simple ambition – to stop men dying from prostate cancer. Through shifting the science over the next 10 years to focus on radical improvements in diagnosis, treatment, prevention, and support, we will stop prostate cancer being a killer.